20 June 2016

UK's Mironid closes $6.2M Series A for cancer and kidney disease projects

Scotland-based cell signaling upstart Mironid has raised £4.3 million ($6.2 million) in its Series A funding round less than a year after being spun out of Glasgow’s University of Strathclyde. The money will help support the fledging biotech’s early-stage research and preclinical development programs--which are currently focused on degenerative kidney disease, major inflammatory disease and cancer. The biotech’s research aims to dial up and down the activity of key cell signaling enzymes to rebalance aberrant signals that drive different disease states. Source: Fierce Biotech 20/6/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).